Caribou Biosciences, Inc.
CRBU
$1.44
-$0.10-6.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -37.46% | -39.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -37.46% | -39.18% | |||
| Cost of Revenue | -8.10% | -13.45% | |||
| Gross Profit | 4.23% | 8.35% | |||
| SG&A Expenses | -2.11% | -5.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.41% | -11.47% | |||
| Operating Income | 3.58% | 7.64% | |||
| Income Before Tax | 3.20% | 7.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.20% | 5.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.20% | 5.30% | |||
| EBIT | 3.58% | 7.64% | |||
| EBITDA | 3.58% | 7.71% | |||
| EPS Basic | 8.14% | 6.60% | |||
| Normalized Basic EPS | 8.07% | 8.56% | |||
| EPS Diluted | 8.14% | 6.60% | |||
| Normalized Diluted EPS | 8.07% | 8.56% | |||
| Average Basic Shares Outstanding | 5.35% | 1.40% | |||
| Average Diluted Shares Outstanding | 5.35% | 1.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||